IPOs and Secondaries
IPOs and Secondaries Articles
Protagonist Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Talend expects to price more than 5 million American depositary shares in the range of $15 to $17 per share in an initial public offering valued up to more than $102 million.
Published:
Last Updated:
Patheon expects to price more than 30 million shares in the range of $19 to $22 per share for a initial public offering valued up to about $771 million.
Published:
Last Updated:
Impinj expects to price more than 4 million shares in the range of $12 to $14 per share for an initial public offering valued up to about $74 million.
Published:
Last Updated:
Audentes Therapeutics expects to price its 5 million shares in the range of $14 to $16, for an initial public offering valued up to $92 million.
Published:
Last Updated:
TPI Composites expects to price more than 7 million shares in the range of $15 to $17 per share for an initial public offering valued up to more than $141 million.
Published:
Last Updated:
First Hawaiian has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were listed in the filing, but the...
Published:
Last Updated:
Forterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
CBS Radio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
24/7 Wall Street has picked out a few companies posting the largest losses last week, including Humana.
Published:
Last Updated:
Of five potential initial public offerings (IPOs) scheduled for last week, just one priced and completed. The other four continue to be listed as day-to-day for the coming week along with two...
Published:
Last Updated:
Ventas Inc. (NYSE: VTR) announced the pricing of its secondary offering recently. The company values its 9 million share offering up to $649 million in terms of gross proceeds. There is also an...
Published:
Last Updated:
Amedica expects to gain about $11 million in gross proceeds from an underwritten secondary offering. The entire offering is valued up to more than $12 million.
Published:
Last Updated:
AdvancePierre Foods expects to price more than 18 million shares in the range of $20 to $23 per share for an initial public offering valued up to nearly $492 million.
Published:
Last Updated:
Yeti Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated: